Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism.
[gm1 gangliosidosis]
Polyomaviruses
are
nonenveloped
viruses
with
capsids
composed
primarily
of
72
pentamers
of
the
viral
VP
1
protein
,
which
forms
the
outer
shell
of
the
capsid
and
binds
to
cell
surface
oligosaccharide
receptors
.
Highly
conserved
VP
1
proteins
from
closely
related
polyomaviruses
recognize
different
oligosaccharides
.
To
determine
whether
amino
acid
changes
restricted
to
the
oligosaccharide
binding
site
are
sufficient
to
determine
receptor
specificity
and
how
changes
in
receptor
usage
affect
tropism
,
we
studied
the
primate
polyomavirus
simian
virus
40
(
SV
40
)
,
which
uses
the
ganglioside
GM
1
as
a
receptor
that
mediates
cell
binding
and
entry
.
Here
,
we
used
two
sequential
genetic
screens
to
isolate
and
characterize
viable
SV
40
mutants
with
mutations
in
the
VP
1
GM
1
binding
site
.
Two
of
these
mutants
were
completely
resistant
to
GM
1
neutralization
,
were
no
longer
stimulated
by
incorporation
of
GM
1
into
cell
membranes
,
and
were
unable
to
bind
to
GM
1
on
the
cell
surface
.
In
addition
,
these
mutant
viruses
displayed
an
infection
defect
in
monkey
cells
with
high
levels
of
cell
surface
GM
1
.
Interestingly
,
one
mutant
infected
cells
with
low
cell
surface
GM
1
more
efficiently
than
wild-
type
virus
,
apparently
by
utilizing
a
different
ganglioside
receptor
.
Our
results
indicate
that
a
small
number
of
mutations
in
the
GM
1
binding
site
are
sufficient
to
alter
ganglioside
usage
and
change
tropism
,
and
they
suggest
that
VP
1
divergence
is
driven
primarily
by
a
requirement
to
accommodate
specific
receptors
.
In
addition
,
our
results
suggest
that
GM
1
binding
is
required
for
vacuole
formation
in
permissive
monkey
CV
-
1
cells
.
Further
study
of
these
mutants
will
provide
new
insight
into
polyomavirus
entry
,
pathogenesis
,
and
evolution
.
Diseases
Validation
Diseases presenting
"high levels"
symptom
22q11.2 deletion syndrome
adrenal incidentaloma
allergic bronchopulmonary aspergillosis
alpha-thalassemia
aromatase deficiency
cadasil
canavan disease
classical phenylketonuria
congenital adrenal hyperplasia
congenital toxoplasmosis
cutaneous mastocytosis
cystinuria
dentin dysplasia
dentinogenesis imperfecta
dracunculiasis
dystrophic epidermolysis bullosa
erythropoietic protoporphyria
gm1 gangliosidosis
hereditary cerebral hemorrhage with amyloidosis
holt-oram syndrome
homocystinuria without methylmalonic aciduria
kabuki syndrome
kallmann syndrome
liposarcoma
papillon-lefèvre syndrome
phenylketonuria
primary effusion lymphoma
primary hyperoxaluria type 1
scrub typhus
severe combined immunodeficiency
systemic capillary leak syndrome
triple a syndrome
von hippel-lindau disease
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom